Enforcement Report - Week of July 24, 2024
Omsav Pharma`s Generic Nitrofurantoin Receives Approval in the U.S.
Mankind's Generic Nitrofurantoin Receives Approval in the U.S.
Aurobindo's Generic Nitrofurantoin Receives Receives Approval in the U.S.
ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP
Aurobindo's Generic Nitrofurantoin Receives Approval in the U.S.
Alvogen Generic Nitrofurantoin Receives Approval in the U.S.
Enforcement Report - Week of May 25, 2022
Drug firm Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator for its generic Nitrofurantoin capsules indicated for the treatment of urinary tract infections. The company has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Nitrofurantoin capsules, USP in the strengths of 25 mg, 50 mg and 100 mg, Alembic Pharma said in a regulatory filing.nnRead more at:nhttps://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-for-generic-nitrofurantoin-capsules/articleshow/84014593.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst